Annual Non Current Assets
$42.08 M
+$25.96 M+161.02%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual long term assets is currently $42.08 million, with the most recent change of +$25.96 million (+161.02%) on 31 December 2023. During the last 3 years, it has risen by +$39.30 million (+1412.98%). PRLD annual non current assets is now at all-time high.PRLD Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$40.83 M
-$744.00 K-1.79%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly long term assets is currently $40.83 million, with the most recent change of -$744.00 thousand (-1.79%) on 30 September 2024. Over the past year, it has increased by +$17.24 million (+73.06%). PRLD quarterly non current assets is now -2.95% below its all-time high of $42.08 million, reached on 31 December 2023.PRLD Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +161.0% | +73.1% |
| 3 y3 years | +1413.0% | +667.5% |
| 5 y5 years | +5088.2% | - |
PRLD Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1413.0% | -3.0% | +667.5% |
| 5 y | 5 years | at high | +5088.2% | -3.0% | +2420.6% |
| alltime | all time | at high | +5088.2% | -3.0% | +2420.6% |
Prelude Therapeutics Incorporated Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $40.83 M(-1.8%) |
| June 2024 | - | $41.58 M(-0.4%) |
| Mar 2024 | - | $41.74 M(-0.8%) |
| Dec 2023 | $235.59 M(+15.3%) | $42.08 M(+78.3%) |
| Sept 2023 | - | $23.59 M(+15.7%) |
| June 2023 | - | $20.40 M(-11.5%) |
| Mar 2023 | - | $23.06 M(+43.0%) |
| Dec 2022 | $204.38 M | $16.12 M(+4.4%) |
| Sept 2022 | - | $15.43 M(+48.0%) |
| June 2022 | - | $10.43 M(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $10.70 M(+7.2%) |
| Dec 2021 | $295.12 M(+33.7%) | $9.98 M(+87.7%) |
| Sept 2021 | - | $5.32 M(+6.3%) |
| June 2021 | - | $5.01 M(+4.0%) |
| Mar 2021 | - | $4.81 M(+73.1%) |
| Dec 2020 | $220.81 M(+991.8%) | $2.78 M(+71.7%) |
| Sept 2020 | - | $1.62 M(-21.0%) |
| June 2020 | - | $2.05 M(+24.5%) |
| Dec 2019 | $20.22 M(+29.7%) | $1.65 M |
| Dec 2018 | $15.60 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual long term assets?
- What is the all time high annual non current assets for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual non current assets year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly long term assets?
- What is the all time high quarterly non current assets for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly non current assets year-on-year change?
What is Prelude Therapeutics Incorporated annual long term assets?
The current annual non current assets of PRLD is $42.08 M
What is the all time high annual non current assets for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual long term assets is $42.08 M
What is Prelude Therapeutics Incorporated annual non current assets year-on-year change?
Over the past year, PRLD annual long term assets has changed by +$25.96 M (+161.02%)
What is Prelude Therapeutics Incorporated quarterly long term assets?
The current quarterly non current assets of PRLD is $40.83 M
What is the all time high quarterly non current assets for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly long term assets is $42.08 M
What is Prelude Therapeutics Incorporated quarterly non current assets year-on-year change?
Over the past year, PRLD quarterly long term assets has changed by +$17.24 M (+73.06%)